CD63 and breast cancer: Although the molecular mechanism underlying the cell invasiveness related to RPN2 remains unknown, our recent study reported that glycosylated CD63 by RPN2 plays an important role in breast cancer cell invasiveness by regulating MDR1 localization [15].